X-ZELL CEO to present at 2018 HealthInvestor Asia Summit

Singapore, March 2018 – X-ZELL is proud to confirm a special presentation by company CEO, Dr Sebastian Bhakdi, at the 2018 HealthInvestor Asia Summit in Singapore on 15 May 2018.

The TED-style presentation will give attendees a world-exclusive first look behind the scenes of X-ZELL’s revolutionary Cryoimmunostaining™ technology, with new insights into early cancer detection that have never before been shared publicly.

Dr Bhakdi will also use the occasion to announce a game-changing new randomised controlled clinical trial to be carried out in collaboration with a world-famous health care organisation, and reflect on the need for more application- and outcome-based research in the biotechnology sector at large.

The HealthInvestor Asia Summit will be held at the Marina Bay Sands in Singapore on 15 May 2018.

Sebastian Grote
Head of Marketing & Communications

Next-generation cytology

© 2024 X-ZELL Biotech Pte. Ltd.

Find Us